Cytodyn Inc (CYDY)

[calstang66]

You say Leronlimab failed its trials. That is a misleading incomplete statement. There are 2 purposes for a trial. To try to meet endpoints and to learn from data. Secondary Endponts were met and data showed a reduction of 24% of deaths in critical patients by leronlimab vs SOC and a reduction of 31.8% of deaths in critical patients 65 and younger. So we shall just ignore that and throw Leronlimab in the trash while 1000 Americans in critical cv19 condition are dying every day, right you idiots and scammers and shorts and deceivers?????? Would it make you happier if 2000 Americans were dying everyday???? Data displays a descent probability that leronlimab would save between 240 to 320 Americans everyday if approved, that is a cold, true, statistical factual "probability". Yes, 240 to 320 lives saved, above what any other available approved drug is doing, so compared to what's available, Leronlimab is by far, the best therapeutic. Opinions don't over-rule data and probabilities.